In the trade, it is called public service journalism, but this may qualify more as a disservice. In the Sept. 21 issue with Tim Tebow on the cover (again?), ESPN Magazine devotes two well-illustrated and detailed pages on performance-enhancing drugs. This is a must read for every attorney who represents an athlete who tests positive. The article probably should not be allowed in the libraries of middle and high schools.
Curious about how to get in shape before pro hockey or baseball season starts? Use Tri-Test, says ESPN. Want to come off a steroid cycle? Do like Manny Ramirez and take HCG. The article explains how each drug works, its legal status with the World Anti-Doping Agency, and why athletes risk taking the product.
The article gives popular other names for a drug; our favorite is Apache, Dance Fever and Goodfella, all of which refer to Fentanyl, a synthetic opiate that ESPN writes has achieved popularity among some weightlifters.
ESPN warns, “Don’t try these at home,” to which we would add, ” or in a clubhouse, at a track meet or in a weight room.”
About Joel Rothman
Joel B. Rothman represents clients in intellectual property infringement litigation involving patents, trademarks, copyrights, trade secrets, defamation, trade libel, unfair competition, unfair and deceptive trade practices, and commercial matters. Joel’s litigation practice also includes significant focus on electronic discovery issues such as e-discovery management and motion practice relating to e-discovery.
